Cajal Neuroscience, a Seattle startup taking a unique approach to developing treatments for neurodegenerative diseases like Alzheimer’s and Parkinson’s, revealed more details about its strategy and announced $96 million in… Read More
Joel Marcus’ fortunes have risen with those of the life sciences industry. The executive chairman of life sciences builder Alexandria Real Estate Equities first bought laboratory space in Seattle in… Read More